BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu CS, Jung SW, Lee JL, Lim SB, Park IJ, Yoon YS, Kim CW, Yang SK, Ye BD, Park SH, Han M, Kim JC. The Influence of Preoperative Medications on Postoperative Complications in Patients After Intestinal Surgery for Crohn's Disease.Inflamm Bowel Dis. 2019;25:1559-1568. [PMID: 30753560 DOI: 10.1093/ibd/izz010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang Y, Yao D, Guo F, Zhou Z, Li Y. Preoperative Anti-TNF Therapy is Associated with a Shorter Length of Resected Bowel in Patients Undergoing Ileocolic Resection for Crohn's Disease. J Invest Surg 2022;:1-9. [PMID: 34983280 DOI: 10.1080/08941939.2021.2023713] [Reference Citation Analysis]
2 Shen J, Yu Y, Wang C, Chu Y, Yan S. Association of preoperative medication with postoperative length of stay in elderly patients undergoing hip fracture surgery. Aging Clin Exp Res 2021;33:641-9. [PMID: 32440842 DOI: 10.1007/s40520-020-01567-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Rocha R, de J Santos G, Santana G. Influence of nutritional status in the postoperative period of patients with inflammatory bowel disease. World J Gastrointest Pharmacol Ther 2021; 12(5): 90-99 [PMID: 34616585 DOI: 10.4292/wjgpt.v12.i5.90] [Reference Citation Analysis]
4 Udholm LS, Rasmussen SL, Madsbøll TK, Omairi M, El-Hussuna A. A systemic review and metaanalysis of postoperative outcomes in urgent and elective bowel resection in patients with Crohn's disease. Int J Colorectal Dis 2021;36:253-63. [PMID: 33048241 DOI: 10.1007/s00384-020-03786-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Uchino M, Ikeuchi H, Shimizu J, Ohge H, Haji S, Mizuguchi T, Mohri Y, Yamashita C, Kitagawa Y, Suzuki K, Kobayashi M, Kobayashi M, Sakamoto F, Yoshida M, Mayumi T, Hirata K, Takesue Y. Association between preoperative tumor necrosis factor alpha inhibitor and surgical site infection after surgery for inflammatory bowel disease: a systematic review and meta-analysis. Surg Today 2021;51:32-43. [PMID: 32277281 DOI: 10.1007/s00595-020-02003-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Grass F, Ansell J, Petersen M, Mathis KL, Lightner AL. Risk factors for 90-day readmission and return to the operating room following abdominal operations for Crohn’s disease. Surgery 2019;166:1068-75. [DOI: 10.1016/j.surg.2019.08.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Law CC, Bell C, Koh D, Bao Y, Jairath V, Narula N. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease. Cochrane Database Syst Rev 2020;10:CD013256. [PMID: 33098570 DOI: 10.1002/14651858.CD013256.pub2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]